Form 8-K Ginkgo Bioworks Holdings For: Feb 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/3/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Jersey Mike's Subs files for IPO on NYSE under ticker JMKE
- Meta CEO Mark Zuckerberg Says In Internal Town Hall That Ai Agent Development Over The Last Four Months Hasn't 'accelerated In The Way We Expected' - Reuters
Ginkgo Bioworks to sell biosecurity unit for 20% stake in Tower Biosecurity
February 27, 2026 6:23 AM ESTGinkgo Bioworks Holdings, Inc. (NYSE: DNA) announced that its subsidiary entered into an agreement to sell substantially all operations of its biosecurity segment to Tower Biosecurity, Inc.
Under the stock purchase agreement dated February 26, 2026, Ginkgo Bioworks, Inc. will transfer all equity interests of... More
